|
home > about prostate cancer > detection > risk assessment
| |
Sponsored by:
|
|
|
Risk Assessment
The following content was provided by Aureon Laboratories
Men newly diagnosed with prostate cancer face difficult choices and, in consultation with their physicians, need better, more objective information.
Prostate Px+ provides critically important information at diagnosis, offering patients and their physicians objective, actionable data when they need it - prior to treatment selection.
At diagnosis, Prostate Px+ can:
- Predict disease progression after prostatectomy
- Assist objective, informed treatment decisions
- Identify high-risk patients presenting as lower risk
- Assess the actual risk of "intermediate-risk" patients
- Assess favorable pathologic stage which may indicate indolent disease
- Help alleviate anxiety
|
About Prostate Px+
